Assignment of Assignor's Interest

Recorded: 2021-01-29 Pages: 3

Assignor

FUSION ANTIBODIES PLC.

Executed: 2020-12-07

Assignee

AMUNIX PHARMACEUTICALS, INC.

2 TOWER PLACE #1100, SOUTH SAN FRANCISCO, CALIFORNIA, 94080-1826

Covered Property (1)

CD3 Antigen Binding Fragments and Compositions Comprising Same

Application: 16/996,899 →

Publication: US 2021/0054077

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.